Skip to content

Acute Myeloid Leukemia T 9 22 Q34 1 Q11 2 Cn305555

Published: July 22, 2026Updated: August 20, 2026

AML with the Philadelphia chromosome, involving chromosomes 9 and 22. This form has a poor outlook but may respond to targeted therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Shortness of breath

(hematologic)

Frequent infections

(hematologic)

Swollen lymph nodes

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Tyrosine Kinase Inhibitor-Based Therapy

BCR-ABL1 targeted therapy with TKIs such as dasatinib or ponatinib combined with chemotherapy. This Philadelphia chromosome-positive AML requires specific targeted approaches alongside conventional treatment.

medication
3

Allogeneic Stem Cell Transplant

Considered the only potentially curative option for Ph+ AML. Transplantation after achieving remission with TKI-based therapy provides the best long-term disease control.

procedure

Additional treatment options

Hyperfractionated Cyclophosphamide

Intensive conditioning regimen incorporating hyper-CVAD with TKI for transplant eligible patients. May provide deeper responses before transplantation.

medication

Physical Function Preservation Program

Structured exercise program adapted for leukemia patients to maintain muscle mass, reduce fatigue, and improve treatment tolerance. Includes aerobic conditioning and resistance training appropriate to treatment phase.

lifestyle

Chronic Illness Adjustment Counseling

Specialized psychological intervention addressing the unique challenges of Ph+ leukemia including treatment uncertainty, family planning decisions, and long-term medication adherence concerns.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia T 9 22 Q34 1 Q11 2 Cn305555?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Arber DA, Borowitz MJ, Cessna M, et al. Initial Diagnostic Workup of Acute Leukemia: Guideline from the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017.

guideline2017
2

Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel. Blood. 2022.

review2022
3

Stone RM, Mandrekar SJ, Sanford BL, et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med. 2017.

clinical_trial2017
4

Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016.

review2016

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia T 9 22 Q34 1 Q11 2 Cn305555. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy